Your browser doesn't support javascript.
loading
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Khan, Muhammad Shahzeb; Marx, Nikolaus; Lam, Carolyn S P; Schnaidt, Sven; Ofstad, Anne Pernille; Brueckmann, Martina; Jamal, Waheed; Bocchi, Edimar A; Ponikowski, Piotr; Perrone, Sergio V; Januzzi, James L; Verma, Subodh; Böhm, Michael; Ferreira, João Pedro; Pocock, Stuart J; Zannad, Faiez; Packer, Milton.
Afiliación
  • Anker SD; Department of Cardiology, Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Germany (S.D.A.).
  • Butler J; Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B., M.S.K.).
  • Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Greece (G.F.).
  • Khan MS; Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B., M.S.K.).
  • Marx N; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany (N.M.).
  • Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.).
  • Schnaidt S; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany (S.S.).
  • Ofstad AP; Medical Department, Boehringer Ingelheim Norway KS, Asker, Norway (A.P.O.).
  • Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.B., W.J.).
  • Jamal W; Faculty of Medicine Mannheim, University of Heidelberg, Germany (M.B.).
  • Bocchi EA; Klinik für Innere Medizin III, Saarland University, Homburg/Saar, Germany (M.B.).
  • Ponikowski P; Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.B., W.J.).
  • Perrone SV; Heart Institute of the University of Sao Paulo (InCor), Brazil (E.A.B.).
  • Januzzi JL; Wroclaw Medical University, Poland (P.P.).
  • Verma S; Hospital de Alta Complejidad El Cruce "Nestor Kirchner," Florencio Varela, Buenos Aires, Argentina (S.V.P.).
  • Böhm M; Harvard Medical School, Massachusetts General Hospital, Boston (J.L.J.).
  • Ferreira JP; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Canada (S.V.).
  • Pocock SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.B., W.J.).
  • Zannad F; Faculty of Medicine Mannheim, University of Heidelberg, Germany (M.B.).
  • Packer M; Klinik für Innere Medizin III, Saarland University, Homburg/Saar, Germany (M.B.).
Circulation ; 143(4): 337-349, 2021 01 26.
Article en En | MEDLINE | ID: mdl-33175585
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Año: 2021 Tipo del documento: Article